Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat infection & inflammation.
Blueberry is committed to the development of innovative therapies to treat diseases where infection and inflammation are major factors.
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
CSO David Cook presented at the recent ELRIG (European Laboratory Research & Innovation Group) held at Alderley Park. David presented [...]
Blueberry Therapeutics are pleased to announce they have dosed the first patient in a Phase I/II clinical trial of BB2603 [...]